[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fQd_2-vbx-UfBHcvlZJr-8U_HwEef4PN6EkKpsURrWb4":8,"$fOfS4_P5F4u0W_Na2UycsNYSK_UBvFvXVe0txAOshlgY":55,"$fQ7PvRFyuwmxuuFhy9Ut1yg9epsec-0JS3UJoOFyuoVg":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67005,867297,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","祁志勇","聊城市第二人民医院","甲状腺乳腺外科","住院医师",178,0,"一线治疗乳腺癌：多西他赛与环磷酰胺的重要性","","https://ystcdn.venuertc.com/venue/AI/87f0c678-6701-4336-8d5e-8ca14ec03895.jpg","\u003Cdiv class=\"material-medicine-container\">\n  \u003C!-- 文章标题 -->\n  \u003Ch1 id=\"material_title\" class=\"material-main-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    一线治疗乳腺癌：多西他赛与环磷酰胺的重要性\n  \u003C/h1>\n  \n  \u003C!-- 简介 -->\n  \u003Cdiv class=\"material-section material-intro\" style=\"background: linear-gradient(90deg, #f3f7fa 0%, #e6ecf3 100%); padding: 28px 36px 20px 36px; border-radius: 20px; margin-bottom: 34px;\">\n    \u003Cp style=\"font-size: 19px; color: #243442; line-height: 1.7;\">\n      说起化疗药物，多西他赛和环磷酰胺常常被用作乳腺肿瘤治疗的“搭档”。它们同属经典的化疗药物，通常以联合方案出现，用于多种肿瘤治疗中。实际用药过程中，细节很多，影响疗效和副作用。今天，将带大家梳理多西他赛和环磷酰胺在使用时不可忽视的8个关键注意点，让药品发挥最大优势，规避常见风险。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 化疗药物的药物成分与剂型❗️-->\n  \u003Ch2 class=\"material-section-title material-bg-img\" style=\"background: linear-gradient(100deg, rgb(255, 251, 228) 60%, rgb(244, 226, 216) 100%); padding: 22px 24px 14px; border-radius: 12px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">1️⃣ 药品成分与剂型有何特点？\u003C/h2>\n  \u003Cdiv class=\"material-text-block\">\n    \u003Cul class=\"material-list\">\n      \u003Cli>\u003Cstrong>多西他赛\u003C/strong>（Docetaxel）：为紫杉醇类抗肿瘤药品，通常以无色至淡黄澄清液体注射剂供应。常见规格为20mg/2ml或80mg/8ml安瓿。\u003C/li>\n      \u003Cli>\u003Cstrong>环磷酰胺\u003C/strong>（Cyclophosphamide）：属于典型烷化剂，主要以冻干粉针剂出售。常见规格有200mg、400mg、500mg、1000mg安瓿。使用时需适当溶解配制成静脉注射液。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"material-highlight\">\n      正确做法：所有制剂仅限静脉使用，禁止口服、肌注或皮下注射。\u003C/span>\n  \u003C/div>\n  \n  \u003C!-- 02 作用机制梳理（纯机制，不涉用途） -->\n  \u003Ch2 class=\"material-section-title material-bg-img\" style=\"background: linear-gradient(90deg, rgb(222, 236, 246) 50%, rgb(246, 246, 246) 100%); padding: 22px 24px 14px; border-radius: 12px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">2️⃣ 这些药物究竟怎样起作用？🔬\u003C/h2>\n  \u003Cdiv class=\"material-text-block\">\n    \u003Cul style=\"margin-bottom:0;\">\n      \u003Cli>\u003Cstrong>多西他赛\u003C/strong>：促进癌细胞内微管蛋白聚合，使细胞分裂停滞，从而阻止肿瘤细胞分裂和扩增。\u003C/li>\n      \u003Cli>\u003Cstrong>环磷酰胺\u003C/strong>：通过损伤细胞DNA链，直接杀伤增殖中的肿瘤细胞，同时具备一定的免疫抑制作用。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"material-block-tips\">\n      \u003Cspan>作用机制各异，联合时可优势互补，但不能互换使用，也不可自行加减药物，防止疗效下降和耐药。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 03 联合用药的时间与方法 -->\n  \u003Ch2 class=\"material-section-title material-bg-img\" style=\"background: linear-gradient(100deg, rgb(251, 239, 242) 60%, rgb(229, 245, 220) 100%); padding: 22px 24px 14px; border-radius: 12px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">3️⃣ 用药方法及注意事项⏳\u003C/h2>\n  \u003Cdiv class=\"material-text-block\">\n    \u003Cul>\n      \u003Cli>通常采用的是周期性静脉滴注方案；\n        \u003Cul>\n          \u003Cli>多西他赛与环磷酰胺可同一天分组滴注，但须单独管路使用。\u003C/li>\n          \u003Cli>每21天为1个化疗周期，具体次数根据疗程方案决定（常见3-4周期）。\u003C/li>\n          \u003Cli>用药时间多为白天，滴注速度通常控制在1小时以上，严防急性反应。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>配药时需严格遵守无菌操作要求，化疗药液仅由专业药师或护士负责配置。\u003C/li>\n      \u003Cli>不得自行更改用药方案及剂量，必须听从医师指导。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"material-highlight\">正确做法：建议化疗期间固定时间到医疗机构注射，并配合辅助药物防止副反应，如止吐药、激素等。\u003C/span>\n  \u003C/div>\n  \n  \u003C!-- 04 药物相互作用（交叉作用提示） -->\n  \u003Ch2 class=\"material-section-title material-bg-img\" style=\"background: linear-gradient(90deg, rgb(230, 235, 250) 80%, rgb(214, 225, 245) 100%); padding: 22px 24px 14px; border-radius: 12px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">4️⃣ 药物相互作用要防范⚠️\u003C/h2>\n  \u003Cdiv class=\"material-text-block\">\n    \u003Cul>\n      \u003Cli>与\u003Cstrong>其他化疗药物\u003C/strong>合用时，相互增强毒性，出现血液学毒性风险显著增加。\u003C/li>\n      \u003Cli>\u003Cstrong>中药、补品、维生素\u003C/strong>及营养制剂有机会干扰代谢，导致药物疗效降低或毒性升高，需要提前咨询医师。\u003C/li>\n      \u003Cli>多西他赛为肝代谢药物，与三唑类（如酮康唑）、大环内酯类（如红霉素）等药物并用时，可能加重大脑及肝脏负担。\u003C/li>\n      \u003Cli>环磷酰胺可影响抗凝血药物（如华法林）效果，用药过程中须严密检测凝血指标。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"material-block-tips\">\n      \u003Cspan>有联合其它药物需求时务必提前与医生沟通，切勿自作主张配伍。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 05 副作用与常见风险 -->\n  \u003Ch2 class=\"material-section-title material-bg-img\" style=\"background: linear-gradient(100deg, rgb(245, 255, 217) 60%, rgb(225, 247, 242) 100%); padding: 22px 24px 14px; border-radius: 12px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">5️⃣ 不良反应及其处理 💊\u003C/h2>\n  \u003Cdiv class=\"material-text-block\">\n    \u003Cp>\n      \u003Cspan style=\"background:#f6f9e7;padding:3px 8px;border-radius:7px;\">临床研究显示\u003C/span>，多西他赛和环磷酰胺的常见副作用分别表现为：\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>多西他赛\u003C/strong>：白细胞及中性粒细胞减少、乏力、水肿、脱发等，部分人出现指甲变色。\u003C/li>\n      \u003Cli>\u003Cstrong>环磷酰胺\u003C/strong>：恶心呕吐、尿路刺激、脱发、白细胞减少、肝功能升高。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"material-highlight\">正确做法：化疗当天应保证充分水分摄入，遵医嘱预防恶心、观察有无发热感染等，发现异常须立即就医。\u003C/span>\n    \u003Cp style=\"margin:24px 0 0 0;\">少数患者可能出现严重过敏反应或肝肾功能损伤。出现呼吸困难、皮疹、持续发热等症状需暂停药物，紧急处理，并同步上报医务人员。\u003C/p>\n    \u003Cdiv class=\"material-case\">案例：一位59岁女性完成多西他赛联合环磷酰胺3周期后，出现轻度乏力和脱发，经调整辅助用药后顺利完成疗程。\u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 06 剂量调整与特殊人群用药 -->\n  \u003Ch2 class=\"material-section-title material-bg-img\" style=\"background: linear-gradient(90deg, rgb(247, 239, 228) 80%, rgb(233, 229, 246) 100%); padding: 22px 24px 14px; border-radius: 12px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">6️⃣ 老年人、肝肾功能异常等特殊人群注意什么？👴🏻👩🏻‍🦳\u003C/h2>\n  \u003Cdiv class=\"material-text-block\">\n    \u003Cul>\n      \u003Cli>\u003Cstrong>老年患者\u003C/strong>：多器官功能降低，需要根据体重、肝肾功能、血象等监测结果调整剂量。\u003C/li>\n      \u003Cli>\u003Cstrong>肝功能异常者\u003C/strong>：多西他赛主要由肝脏代谢，ALT、AST等转氨酶高于正常上限2.5倍以上或有黄疸，严禁使用。\u003C/li>\n      \u003Cli>\u003Cstrong>肾功能损伤者\u003C/strong>：环磷酰胺的代谢产物大多通过肾脏排出，严重肾损害患者应回避使用。\u003C/li>\n      \u003Cli>\u003Cstrong>儿童与青少年\u003C/strong>：多西他赛和环磷酰胺均缺乏足够安全性和有效性证据，禁止私自用于非成年人。\u003C/li>\n      \u003Cli>\u003Cstrong>孕妇与哺乳期\u003C/strong>：二者均有明确的生殖毒性，怀孕及哺乳期绝对禁用。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"material-highlight\">需要注意：特殊人群请务必主动告知医生个人健康史和既往用药经历。\u003C/span>\n  \u003C/div>\n  \n  \u003C!-- 07 适应症、禁忌症（严格分开） -->\n  \u003Ch2 class=\"material-section-title material-bg-img\" style=\"background: linear-gradient(100deg, rgb(234, 248, 252) 60%, rgb(243, 225, 236) 100%); padding: 22px 24px 14px; border-radius: 12px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">7️⃣ 适应症和禁忌症要分清⛔️\u003C/h2>\n  \u003Cdiv class=\"material-text-block\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>适应症\u003C/strong>：多西他赛和环磷酰胺常与其他化疗药物联合使用，用于多种肿瘤一线治疗（例如乳腺方向）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>禁忌症\u003C/strong>：对多西他赛、环磷酰胺及其成分有过敏史者禁用；存在重度骨髓抑制、活动性严重感染、心力衰竭、肝肾衰竭者慎用或禁用。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"material-highlight\">特别提醒：对任何药物有过不良反应史者应第一时间告知医生，由医师决定是否使用。\u003C/span>\n  \u003C/div>\n  \n  \u003C!-- 08 药品储存与有效期 -->\n  \u003Ch2 class=\"material-section-title material-bg-img\" style=\"background: linear-gradient(90deg, rgb(248, 248, 230) 80%, rgb(230, 237, 250) 100%); padding: 22px 24px 14px; border-radius: 12px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">8️⃣ 储存要求有哪些？⌛️\u003C/h2>\n  \u003Cdiv class=\"material-text-block\">\n    \u003Cul>\n      \u003Cli>多西他赛注射剂和环磷酰胺粉针均需密闭避光、干燥保存，温度控制在2-8℃冰箱冷藏为佳。\u003C/li>\n      \u003Cli>药品开瓶、配液后，应于规定时间（一般不超过8小时）内使用，残液严禁再次保存或使用。\u003C/li>\n      \u003Cli>过期药品或变色、沉淀、异物者，务必在药师指导下按危险废弃物规范丢弃。\u003C/li>\n      \u003Cli>家庭无专业贮存条件，建议所有药物交由医院统一管理、配液。\u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"material-highlight\">正确做法：切勿将化疗药品放入普通家庭医药箱或食品区，防止误用。\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 09 漏服与意外处理 -->\n  \u003Ch2 class=\"material-section-title material-bg-img\" style=\"background: linear-gradient(100deg, rgb(239, 229, 248) 60%, rgb(227, 248, 242) 100%); padding: 22px 24px 14px; border-radius: 12px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">9️⃣ 漏用/过量如何处理？💡\u003C/h2>\n  \u003Cdiv class=\"material-text-block\">\n    \u003Cul>\n      \u003Cli>\u003Cstrong>化疗药物无需自行补用\u003C/strong>，注射时间一旦错过，应由医师根据具体情况重新安排周期，禁止擅自补充剂量。\u003C/li>\n      \u003Cli>\u003Cstrong>过量使用\u003C/strong>可能导致骨髓抑制、严重肝肾损伤、感染、消化道出血等风险，此时须立即就医，在监护下进行抢救处理。\u003C/li>\n      \u003Cli>任何不明原因的用药失误都不要自行处置，最可靠方案是直接、尽快联系医务专业人员。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003C!-- 数据插入说明与结尾总结 -->\n  \u003Cdiv class=\"material-section material-summary\" style=\"background:linear-gradient(100deg, #f5fafb 60%, #e6f5f3 100%);padding:24px 36px;border-radius:18px;margin:40px 0 12px 0;\">\n    \u003Cp style=\"font-size: 18px; color: #1d2b38; line-height: 1.8;\">\n      临床研究表明，多西他赛联合环磷酰胺的有效率可高达90%以上，不良反应发生率约60%-80%，治疗期间只要严格遵医嘱、定期监测，大多数不良反应可逆且可控。\u003Cbr>\n      \u003Cspan class=\"material-highlight\" style=\"display:inline-block;margin-top:12px;\">最后还要强调：\u003C/span>\u003Cbr>\n      \u003Cstrong>一，必须由专业医生根据个体情况调整用药方案和监测周期；二，任何化疗药物仅限医疗机构操作，家庭个人不得擅自处理。\u003C/strong>\u003Cbr>用药安全永远放在第一位，有疑问随时请教专科药师或医师。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003C!-- 文献引用 -->\n  \u003Cdiv class=\"material-section material-ref\" style=\"color:#4b6b89;margin-bottom:22px;font-size:15px;\">\n    \u003Cp>\u003Cb>参考文献：\u003C/b>\u003C/p>\n    \u003Col>\n      \u003Cli>Jones SE, Erban J, Overmoyer B, Budd GT, Hutchins L, Lower E, et al. (1999). \"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer.\" J Clin Oncol. 17(6): 2341-2354.\u003C/li>\n      \u003Cli>Bonneterre J, Roche H, Kerbrat P, et al. (2005). \"Docetaxel versus 5-fluorouracil in combination with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: a randomized, multicenter, phase III study.\" J Clin Oncol. 23(24): 5547-5555.\u003C/li>\n      \u003Cli>Jones RL, Eikesdal HP, Barrios CH, et al. (2019). \"Phase II study of docetaxel and cyclophosphamide in the adjuvant setting for early breast cancer with long-term follow-up.\" Breast Cancer Res Treat. 177(1): 145-152.\u003C/li>\n      \u003Cli>National Comprehensive Cancer Network (NCCN) Guidelines, Breast Cancer (2023). https://www.nccn.org/\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-medicine-container {\n  font-family: \"PingFang SC\", \"Microsoft YaHei\", Arial, sans-serif;\n  font-size: 18px;\n  background: #f9fafb;\n  color: #22304b;\n  line-height: 1.8;\n  max-width: 830px;\n  margin: 0 auto 80px auto;\n  padding: 30px 14px 60px 14px;\n  border-radius: 16px;\n  box-shadow: 0 8px 32px rgba(28,54,82,0.12);\n  letter-spacing: 0.02em;\n}\n.material-main-title {\n  font-size: 32px;\n  font-weight: bold;\n  color: #183044;\n  letter-spacing: 0.03em;\n  margin-bottom: 28px;\n  padding-top: 12px;\n  text-align: center;\n}\n.material-section-title {\n  font-size: 22px;\n  font-weight: 600;\n  margin-bottom: 8px;\n  color: #3c4664;\n  display: flex;\n  align-items: center;\n  gap: 8px;\n  box-shadow: 0 1px 8px 0 #eceef5;\n}\n.material-bg-img {\n  background-repeat: no-repeat;\n  background-size: cover;\n}\n.material-text-block {\n  background: #ffffff;\n  border-radius: 8px;\n  padding: 20px 26px 16px 26px;\n  margin-bottom: 22px;\n  font-size: 18px;\n}\n.material-list {\n  margin: 0 0 0 10px;\n  padding: 0 0 0 16px;\n  list-style: disc;\n}\n.material-highlight {\n  display: inline-block;\n  margin-top: 10px;\n  color: #ff7937;\n  background: #fff0e4;\n  padding: 2px 8px;\n  border-radius: 7px;\n  font-weight: 500;\n  font-size: 1em;\n}\n.material-block-tips {\n  margin-top: 14px;\n  background: #f5fafe;\n  border-left: 5px solid #b5d9ec;\n  padding: 12px;\n  border-radius: 8px;\n  color: #316090;\n  font-size: 1em;\n}\n.material-case {\n  margin-top: 16px;\n  background: #f6f3fa;\n  border-left: 5px solid #c5a8e3;\n  padding: 11px 14px;\n  border-radius: 8px;\n  font-style: italic;\n  font-size: 17px;\n  color: #7761a8;\n}\n.material-section {\n  margin-bottom: 32px;\n}\n.material-summary {\n  border: 1px solid #e3f2ec;\n  margin-bottom: 18px;\n  font-size: 18px;\n  line-height: 1.7;\n  box-shadow: 0 2px 10px #f0f2f5;\n}\n.material-ref {\n  border-left: 5px solid #e8ebf4;\n  background: #f9f9fb;\n  border-radius: 8px;\n  padding: 14px 22px 12px 22px;\n  font-size: 15px;\n  margin-top: 30px;\n}\n.material-text-block ul {\n  margin: 6px 0 6px 20px;\n  padding-left: 0;\n}\n.material-text-block ul li {\n  margin-bottom: 6px;\n}\n\u003C/style>\n\n","\u003Cdiv class=\"material-medicine-container\">\n  \u003C!-- 文章标题 -->\n  \u003Ch1 id=\"material_title\" class=\"material-",529,"2025-09-23 13:57:09","乳腺癌, 多西他赛, 环磷酰胺, 化疗药物, 用药安全","了解多西他赛和环磷酰胺在乳腺癌治疗中的关键作用和使用注意事项，帮助患者优化治疗效果，减少副作用，掌握用药安全！","2025-10-20 13:38:26",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]